Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

As emerging markets continue to drive global growth, IMS Health takes a look at the healthcare system in India and the key market drivers and game changers for pharma, ahead of the upcoming CPhI ...

AstraZeneca Pharma India Ltd. has received approval from CDSCO to import and sell Lynparza (Olaparib) in India. Lynparza will ...

The Central Drugs Standard Control Organisation granted approval for the drug's use in combination with Durvalumab for the ...

Olaparib in combination with Durvalumab is indicated for the maintenance treatment of adult patients with advanced or ...

Mumbai: Strides Pharma Science Limited, on Tuesday, announced that the National Company Law Tribunal (NCLT), Mumbai Bench, ...

While there are potential risks associated with changes in duty structures and broader geopolitical dynamics, India's ...

Bangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from ...

Emcure's growth will be driven by upbeat prospects that the company has across markets in India, Canada and Rest of World, ...